Neonc Technologies Holdings, Inc. (NTHI): Cash & Equivalents
$58.7K
As of 2025-12-31
$1.97M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.7K | -9.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $64.9K | n/a | 2026-03-31, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $58.7K | -9.5% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $43.76M | +18.5% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $60.18M | -43.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $3.0K | -99.8% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.95M | -58.2% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $5.89M | -33.5% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗